Value-Based Model for Vascular Access Management in the End-Stage Kidney Disease Population
{{output}}
Background: Value-based medicine (VBM) seeks to maximize patient-relevant outcomes per unit cost. In end-stage kidney disease (ESKD), vascular access (VA) is a dominant, modifiable driver of morbidity, mortality, and expenditure.... ...
